abstract |
Provided herein are compounds, pharmaceutical compositions comprising the compounds, methods of preparing the compounds, and methods of using the compounds and compositions in treating diseases or disorders in a subject where the subject is in need of an inhibitor of MEK where the compound is according to formula (I): where R 1 , R 2 , R 2a , R 3 , R 3a , R 3b , and subscript n are as described herein. |